ScholarIQanswers from OpenAlex & ORCID
Karine Clément
ResearcherPublications, citations & collaboration network
Karine Clément is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Karine Clément have?
ScholarIQindexed works
Karine Clément has 676 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Karine Clément have?
ScholarIQcitation count
Karine Clément has 61,884 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Karine Clément?
ScholarIQh-index
Karine Clément has an h-index of 125 in OpenAlex.
What is the i10-index of Karine Clément?
ScholarIQi10-index
Karine Clément has an i10-index of 373 in OpenAlex.
What is the ORCID of Karine Clément?
ScholarIQorcid
The ORCID for Karine Clément is on the source record.
What is the OpenAlex record for Karine Clément?
ScholarIQopenalex
The OpenAlex for Karine Clément is on the source record.
What are the most-cited papers on Karine Clément?
ScholarIQmost cited works
Leptin regulation of bone resorption by the sympathetic nervous system and CART
Florent Elefteriou, Jong Deok Ahn, Shu Takeda, Michael W. Starbuck, Xiangli Yang, Xiuyun Liu, Hisataka Kondo, William G. Richards, Tony W. Bannon, Masaki Noda, Karine Clément, Christian Vaisse, Gérard Karsenty
Gut microbiota and human NAFLD: disentangling microbial signatures from metabolic disorders
Judith Aron‐Wisnewsky, Chloé Vigliotti, Julia J. Witjes, Phuong Thi Le, Adriaan G. Holleboom, Joanne Verheij, Max Nieuwdorp, Karine Clément
Genetic deficiency and pharmacological stabilization of mast cells reduce diet-induced obesity and diabetes in mice
Jian Liu, Adeline Divoux, Jiusong Sun, Jie Zhang, Karine Clément, Jonathan N. Glickman, Galina K. Sukhova, Paul J. Wolters, Juan Du, Cem Z. Görgün, Alessandro Doria, Peter Libby, Richard S. Blumberg, Barbara B. Kahn, Gökhan S. Hotamışlıgil, Guo‐Ping Shi
Genome-wide association study of non-alcoholic fatty liver and steatohepatitis in a histologically characterised cohort☆
Quentin M. Anstee, Rebecca Darlay, Simon Cockell, Marica Meroni, Olivier Govaere, Dina Tiniakos, Alastair D. Burt, Pierre Bédossa, Jeremy M. Palmer, Yang‐Lin Liu, Guruprasad P. Aithal, Michael Allison, Hannele Yki‐Järvinen, Michèle Vacca, Jean‐François Dufour, Pietro Invernizzi, Daniele Prati, Mattias Ekstedt, Stergios Kechagias, Sven Francque, Salvatore Petta, Elisabetta Bugianesi, Karine Clément, Vlad Ratziu, Jörn M. Schattenberg, Luca Valenti, Christopher P. Day, Heather J. Cordell, Ann K. Daly
Efficacy and safety of setmelanotide, an MC4R agonist, in individuals with severe obesity due to LEPR or POMC deficiency: single-arm, open-label, multicentre, phase 3 trials
Karine Clément, Erica L T van den Akker, Jesús Argente, Allison Bahm, Wendy K Chung, Hillori Connors, Kathleen De Waele, I. Sadaf Farooqi, Julie Gonneau-Lejeune, Gregory Gordon, Katja Kohlsdorf, Christine Poitou, Lia Puder, James Swain, Murray Stewart, Guojun Yuan, Martin Wabitsch, Peter Kühnen, Patricia Pigeon-Kherchiche, Anna Flaus-Furmaniuk, Martin Bald, Christian Denzer, Julia von Schnurbein, Ozair Abawi, Ulrike Blume‐Peytavi, Philipp Krabusch, Knut Mai, Dirk Schnabel, Susanna Wiegand, Christa E. Flück, Esther Schulz, Egbert Voß, Nataša Bratina, Katja Weiß, Gabriel Ángel Martos‐Moreno, Alban Danset, Paul Gougis, Béatrice Dubern, Karine Clément, Erica L T van den Akker, Jesús Argente, Allison Bahm, Wendy K Chung, Hillori Connors, Kathleen De Waele, I. Sadaf Farooqi, Julie Gonneau-Lejeune, Gregory Gordon, Christine Poitou, Lia Puder, James Swain, Murray Stewart, Goujun Yuan, Martin Wabitsch, Peter Kühnen